HHS Releases Revised Instructions for Upcoming Prescription Drug and Health Care Spending Reports
The Department of Health and Human Services (HHS) has released revised instructions for group...
House Committee Launches Probe Into PBMs
The U.S. House Oversight and Accountability Committee has launched an investigation into pharmacy...
HHS Secretary Responds to the President’s Executive Order on Drug Prices
On In response to President Joe Biden’s executive order on lowering prescription drug costs...
Feds Extend Prescription Drug Filing Deadline, Announce Relaxed Enforcement
The Departments of Labor, Health and Human Services, and the Treasury (collectively, the...
Submission Grace Period Issued for Prescription Drug Reporting
The transparency provisions of the No Surprises Act require group health plans and health...
December 27 Due Date for Prescription Drug Cost Reporting is Approaching
As part of the Consolidated Appropriations Act of 2021 (CAA), group health plans and carriers...
Health Plan Disclosure Requirements for Prescription Drugs
Under the Affordable Care Act (ACA) transparency-in-coverage (TiC) rules and provisions of the...
No Surprises Act: Transparency Reporting Pharmacy & Drug Costs
The No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA),...
New Biden Administration Plan Aims to Lower Drug Prices
On Thursday, Sept. 9, 2021, President Joe Biden’s administration announced a plan to lower...
Mental Health and Substance Use Disorder Benefits Parity
Consolidated Appropriations Act, 2021
The Consolidated Appropriation Act, 2021...
CMS Updates FAQs on Section 111 MSP Prescription Drug Coverage Reporting
As background, in August 2019, the Centers for Medicare and Medicaid Services (CMS) revised its...
